PASITHEA THERAPEUTICS CORP. Proceeds from Sale of Treasury Stock
PASITHEA THERAPEUTICS CORP. (KTTA) reported Proceeds from Sale of Treasury Stock of $21.86 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfTreasuryStock · last filed 2022-03-30
- PASITHEA THERAPEUTICS CORP. proceeds from sale of treasury stock for the quarter ending 2021-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. proceeds from sale of treasury stock for fiscal 2021 was $21.86M.
| Period end | Proceeds from Sale of Treasury Stock 3 month | Proceeds from Sale of Treasury Stock 5 month | Proceeds from Sale of Treasury Stock 9 month | Proceeds from Sale of Treasury Stock 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $21.86M 10-K · filed 2022-03-30 | ||
| 2021-09-30 | $21.86M 10-Q · filed 2021-11-18 | |||
| 2020-09-30 | $33.00K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |